Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion
David Westenberg

David Westenberg Analyst Performance

Sr. Research Analyst at Piper Sandler

David Westenberg is a stock analyst at Piper Sandler focused in the medical sector, covering 23 publicly traded companies. Over the past year, David Westenberg has issued 43 stock ratings, including buy and hold recommendations. While full access to David Westenberg's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Westenberg's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
78 Last 6 Years
Buy Recommendations
51.95% 40 Buy Ratings
Companies Covered
23 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy51.9%39 ratings
Hold48.1%37 ratings
Sell0.0%0 ratings

Out of 77 total stock ratings issued by David Westenberg at Piper Sandler, the majority (51.9%) have been Buy recommendations, followed by 48.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
82.6% of companies on NASDAQ
19 companies
NYSE
17.4% of companies on NYSE
4 companies

David Westenberg, an analyst at Piper Sandler, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
20 companies
87.0%
Services
2 companies
8.7%
Finance
1 company
4.3%

David Westenberg of Piper Sandler specializes in stock coverage within the Medical sector, with additional focus on Services and Finance companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
8 companies
34.8%
MEDICAL INFO SYS
3 companies
13.0%
MEDICAL SERVICES
3 companies
13.0%
SERVICES – HEALTH
2 companies
8.7%
MED INSTRUMENTS
2 companies
8.7%
MED - OUTP/HM CRE
2 companies
8.7%
MED - DRUGS
1 company
4.3%
MED PRODUCTS
1 company
4.3%
INS - ACC & HLTH
1 company
4.3%

About David Westenberg

David Westenberg is senior research analyst and managing director at Piper Sandler covering animal health and genomics tools and labs. Prior to joining Piper Sandler in 2021, Westenberg was a senior analyst at Guggenheim Securities, covering diagnostics labs, genomic instruments and animal health. Prior to joining Guggenheim, he was a senior analyst at CL King, leading the coverage of diagnostics and animal health. Westenberg is a CFA Charterholder, and was a StarMine runner-up for stock picking in medical equipment in 2018. He has a master’s in finance from Bocconi University in Milan and a Bachelor of Science in business administration from San Francisco State.
Follow on LinkedIn

David Westenberg's Ratings History at Piper Sandler

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
GRAIL, Inc. stock logo
GRAL
GRAIL
5/6/2026Boost Price Target$54.40$56.00Neutral
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
5/5/2026Reiterated Rating$15.12$15.00Neutral
Caris Life Sciences, Inc. stock logo
CAI
Caris Life Sciences
4/10/2026Initiated Coverage$19.20$21.00Neutral
GRAIL, Inc. stock logo
GRAL
GRAIL
4/10/2026Initiated Coverage$47.56$54.00Neutral
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2/24/2026Reiterated Rating$87.08$130.00Overweight
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2/24/2026Boost Price Target$9.97$13.00Overweight
Labcorp Holdings Inc. stock logo
LH
Labcorp
2/24/2026Boost Price Target$285.15$300.00Neutral
Guardant Health, Inc. stock logo
GH
Guardant Health
2/24/2026Boost Price Target$94.42$130.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
2/9/2026Lower Price Target$118.34$170.00Overweight
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2/9/2026Lower Price Target$644.61$750.00Neutral
Zoetis Inc. stock logo
ZTS
Zoetis
1/22/2026Reiterated Rating$125.08$135.00Neutral
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
1/22/2026Upgrade$24.38$30.00Overweight
Zoetis Inc. stock logo
ZTS
Zoetis
1/22/2026Downgrade$124.35$135.00Neutral
Neogen Corporation stock logo
NEOG
Neogen
1/12/2026Reiterated Rating$9.62$10.00Neutral
Billiontoone, Inc. stock logo
BLLN
Billiontoone
12/10/2025Reiterated Rating$109.53Overweight
Billiontoone, Inc. stock logo
BLLN
Billiontoone
12/1/2025Initiated Coverage$130.18$150.00Overweight
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/24/2025Downgrade$101.00$105.00Hold
10x Genomics stock logo
TXG
10x Genomics
11/11/2025Boost Price Target$17.14$19.00Neutral
Tempus AI, Inc. stock logo
TEM
Tempus AI
11/11/2025Lower Price Target$73.40$80.00Neutral
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
11/11/2025Boost Price Target$1.82$2.00Neutral
Natera, Inc. stock logo
NTRA
Natera
11/11/2025Boost Price Target$208.87$230.00Overweight
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
11/11/2025Boost Price Target$28.68$30.00Neutral
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/11/2025Boost Price Target$67.18$80.00Overweight
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
11/11/2025Lower Price Target$4.79$7.50Overweight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
10/27/2025Boost Price Target$182.51$200.00Neutral
Tempus AI, Inc. stock logo
TEM
Tempus AI
10/22/2025Boost Price Target$89.29$105.00Neutral
Guardant Health, Inc. stock logo
GH
Guardant Health
10/22/2025Boost Price Target$68.32$90.00Overweight
Neogen Corporation stock logo
NEOG
Neogen
10/16/2025Set Price Target$5.95$6.50Neutral
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
10/15/2025Boost Price Target$15.58$20.00Overweight
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
10/8/2025Boost Price Target$57.75$70.00Overweight
10x Genomics stock logo
TXG
10x Genomics
9/11/2025Initiated Coverage$12.59$15.00Neutral
GeneDx Holdings Corp. stock logo
WGS
GeneDx
9/11/2025Boost Price Target$129.25$140.00Overweight
Zoetis Inc. stock logo
ZTS
Zoetis
8/11/2025Boost Price Target$147.34$215.00Overweight
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
8/11/2025Reiterated Rating$658.06$700.00Neutral
Natera, Inc. stock logo
NTRA
Natera
8/11/2025Reiterated Rating$151.95$220.00Overweight
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
8/11/2025Boost Price Target$16.61$18.00Neutral
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
8/11/2025Lower Price Target$40.99$60.00Overweight
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
8/11/2025Boost Price Target$1.35$1.50Neutral
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
8/6/2025Boost Price Target$11.34$15.00Overweight
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
8/4/2025Set Price Target$5.45$11.00Overweight
Nobody Understands Why Trump Is Invading Iran (here’s the answer) (Ad)

Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.tc pixel

Discover the real reason behind the Iran strikes before markets react
GeneDx Holdings Corp. stock logo
WGS
GeneDx
8/4/2025Set Price Target$105.18$120.00Overweight
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
8/4/2025Set Price Target$18.18$21.00Neutral
GeneDx Holdings Corp. stock logo
WGS
GeneDx
7/9/2025Initiated Coverage$85.22$110.00Overweight
Tempus AI, Inc. stock logo
TEM
Tempus AI
5/15/2025Boost Price Target$63.76$70.00Neutral
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
5/15/2025Lower Price Target$1.06$1.25Neutral
Natera, Inc. stock logo
NTRA
Natera
5/15/2025Boost Price Target$149.42$210.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
5/15/2025Lower Price Target$80.65$185.00Overweight
Zoetis Inc. stock logo
ZTS
Zoetis
5/12/2025Boost Price Target$162.37$210.00Overweight
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
5/6/2025Set Price Target$7.84$12.00Overweight
Labcorp Holdings Inc. stock logo
LH
Labcorp
5/6/2025Reiterated Rating$245.96$280.00Neutral
Guardant Health, Inc. stock logo
GH
Guardant Health
5/6/2025Reiterated Rating$43.68$60.00Overweight
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
5/6/2025Reiterated Rating$18.96$23.00Neutral
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
5/6/2025Reiterated Rating$10.03$13.00Overweight
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4/28/2025Boost Price Target$175.47$200.00Neutral
Neogen Corporation stock logo
NEOG
Neogen
4/22/2025Lower Price Target$4.82$5.00Neutral
Neogen Corporation stock logo
NEOG
Neogen
4/14/2025Lower Price Target$5.58$6.50Neutral
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
4/14/2025Lower Price Target$1.23$1.65Neutral
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
3/6/2025Lower Price Target$10.77$12.00Neutral
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
3/4/2025Lower Price Target$4.30$8.00Overweight
Tempus AI, Inc. stock logo
TEM
Tempus AI
3/4/2025Lower Price Target$50.13$55.00Neutral
Natera, Inc. stock logo
NTRA
Natera
3/4/2025Boost Price Target$137.97$205.00Overweight
Fulgent Genetics, Inc. stock logo
FLGT
Fulgent Genetics
3/4/2025Lower Price Target$14.98$16.00Neutral
Zoetis Inc. stock logo
ZTS
Zoetis
2/27/2025Boost Price Target$164.99$205.00Overweight
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2/26/2025Lower Price Target$10.64$18.00Overweight
Guardant Health, Inc. stock logo
GH
Guardant Health
2/26/2025Boost Price Target$43.13$50.00Overweight
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
2/26/2025Lower Price Target$48.71$70.00Overweight
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2/20/2025Reiterated Rating$1.63$2.00Neutral
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
2/20/2025Reiterated Rating$8.48$11.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
2/10/2025Boost Price Target$103.65$190.00Overweight
Zoetis Inc. stock logo
ZTS
Zoetis
2/10/2025Lower Price Target$171.12$200.00Overweight
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2/10/2025Boost Price Target$463.58$510.00Neutral
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2/3/2025Reiterated Rating$161.06$180.00Neutral
Neogen Corporation stock logo
NEOG
Neogen
1/21/2025Reiterated Rating$11.78$13.00Neutral